Requires Adobe Acrobat Reader

Table 13.8

Adjusted Graft Survival, Heart-Lung Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

		3 Months			1 Year			5 Years			10 Years
		(Tx 2006 - 2007)			(Tx 2006 - 2007)			(Tx 2002 - 2007)			(Tx 1997 - 2007)
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	62	85.5%	4.4%	62	80.5%	5.0%	194	43.2%	5.3%	426	25.8%	3.2%
Primary Diagnosis	Congenital Disease	9	54.3%	16.4%	9	54.3%	16.4%	47	40.4%	7.5%	142	16.3%	4.5%
	Cystic Fibrosis	3	+	+	3	+	+	7	0.0%	0.0%	12	19.7%	12.8%
	Emphysema/COPD	1	100.0%	0.0%	1	0.0%	0.0%	2	0.0%	0.0%	12	37.1%	13.8%
	Other	10	+	+	10	+	+	26	67.5%	10.4%	44	21.4%	10.3%
	Unknown	22	91.6%	5.7%	22	83.1%	7.8%	57	43.5%	10.8%	115	27.1%	6.4%

Source: OPTN/SRTR Data as of May 4, 2009.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.

Requires Adobe Acrobat Reader